Treanda
Product Images NDC 63459-396

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Treanda (NDC 63459-396). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cephalon, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

FDA Label Image

Figure 1. Progression-free Survival (Image 2)

FDA Label Image

25 mg Carton (Image 3)

25 mg Carton (Image 3)
This appears to be a label for a medication called Treanda, which is administered via intravenous injection. The medication contains bendamustine HCI and is considered a cytotoxic agent. The label includes dosing information, storage instructions, and details on how to reconstitute the medication. The vials are single-use, and any unused portions should be discarded. The label advises using gloves and glasses when handling the medication due to its classification as a cytotoxic agent.*
FDA Label Image

100 mg Carton (Image 4)

100 mg Carton (Image 4)
The text describes a medication called Treanda, which contains the drug bendamustine HCI. It is for intravenous infusion only and requires reconstitution and dilution. Reconstitution instructions can be found in the insert. The medication should be used cautiously and gloves and safety glasses are recommended during handling and preparation. The medication comes in a single-use vial and unused portions should be discarded. The usual dosage recommendation is to reconstitute Treanda with sterile water or injection and for immediate further dilution. The reconstituted solution should be used within 24 hours, either when stored refrigerated or at room temperature, as outlined in the insert.*
FDA Label Image

Packaging (Image 5)

Packaging (Image 5)
Not available.*
FDA Label Image

Packaging (Image 6)

Packaging (Image 6)
This is a pharmaceutical label for Treanda (bendamustine HCl) injection, a drug used for intravenous fusion. The dosage is 180mg/2mL and must be stored refrigerated at 2-8°C. The label includes instructions for use, handling, and disposal of the drug. The text also includes some unreadable characters and may have some errors due to .*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.